Cargando…
Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease
There are currently no effective pharmacological agents available to stop or prevent the progression of Huntington’s disease (HD), a rare hereditary neurodegenerative disorder. In addition to psychiatric symptoms and cognitive impairments, HD causes progressive motor disturbances, in particular chor...
Autores principales: | Coppen, Emma M., Roos, Raymund A. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216093/ https://www.ncbi.nlm.nih.gov/pubmed/27988871 http://dx.doi.org/10.1007/s40265-016-0670-4 |
Ejemplares similares
-
Atrophy of the putamen at time of clinical motor onset in Huntington’s disease: a 6-year follow-up study
por: Coppen, Emma M., et al.
Publicado: (2018) -
Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease
por: Coppen, Emma M, et al.
Publicado: (2019) -
Structural and functional changes of the visual cortex in early Huntington's disease
por: Coppen, Emma M., et al.
Publicado: (2018) -
Early grey matter changes in structural covariance networks in Huntington's disease
por: Coppen, Emma M., et al.
Publicado: (2016) -
The Many Faces of Huntington’s Chorea Treatment: The Impact of Sudden Withdrawal of Tiapride after 40 Years of Use and a Systematic Review
por: Feleus, Stephanie, et al.
Publicado: (2022)